Novogen Announces Preclinical Studies Justifies Mode Of Delivery And Dosing Regimen For Anisina
November 10, 2015 at 16:18 PM EST
US-Australian drug discovery company, Novogen Limited (NASDAQ: NVGN), today announced details of preclinical studies which confirm the ...